Tweeter button Delicious button Digg button Stumbleupon button
Hepatitis | Research And Markets: Hepatitis A – Pipeline Review, H1 2012

Research and Markets ( ) has announced the addition of Global Markets Direct’s new report “Hepatitis A – Pipeline Review, H1 2012″ to their offering.

Global Markets Direct’s, ‘Hepatitis A – Pipeline Review, H1 2012′, provides an overview of the Hepatitis A therapeutic pipeline. This report provides information on the therapeutic development for Hepatitis A, complete with latest updates, and special features on late-stage and discontinued projects.

It also reviews key players involved in the therapeutic development for Hepatitis A. ‘Hepatitis A – Pipeline Review, H1 2012′ is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.


Scope

– A snapshot of the global therapeutic scenario for Hepatitis A.

– A review of the Hepatitis A products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

– Coverage of products based on various stages of development ranging from discovery till registration stages.

– A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

– Coverage of the Hepatitis A pipeline on the basis of route of administration and molecule type.


Click here to view rest of article from original site

The Hepatitis C Handbook  by Matthew Dolan The Hepatitis C Handbook  by Matthew Dolan

27 new from $4.98
Dr. Melissa Palmer's Guide To Hepatitis And Liver Disease  by Melissa Dr. Melissa Palmer’s Guide To Hepatitis And Liver Disease  by Melissa
almer



Facebook Twitter Email

Important Disclaimer: Article Comments provided are for general information purposes only and are not intended to substitute for informed professional medical, psychological, tax, accounting, legal, investment, or any other professional advice. We expressly disclaim liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in these comments or anywhere else within the site. Lastly, we do not endorse any article or comment. Use at your own risk.